About COGNITIVE SYNERGY CORP
Cognitive Synergy Corporation is a biotechnology company developing novel small-molecule therapies for Alzheimer’s disease and related neurodegenerative disorders. Their lead candidate aims to restore synaptic health and reduce amyloid and tau pathology, potentially offering the first disease-modifying treatment for Alzheimer’s.
Developing novel small-molecule therapies for Alzheimer’s disease and related neurodegenerative disordersReducing toxic amyloid and tau pathology while restoring synaptic integrityAdvancing preclinical research with translational biomarkers and pharmacologyConducting IND-enabling studies for clinical development
Is this your company?
Claim this profile to keep it accurate — and see the federal & state opportunities GovIntel's AI has matched to COGNITIVE SYNERGY CORP right now.
Claim this profile See matched opportunitiesData compiled from public government sources including SAM.gov, USAspending.gov, and state procurement records. Last verified against federal award records. Inaccurate? Let us know.